Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn7resultaten gevonden
Farmaco-epidemiologie

Sekseverschillen bij cardiovasculaire medicatie

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Armanda Evelo
  • Promoters L.E Visser (EMC/Haga) B. Koch (EMC)
  • Jaar 2022-2026
Farmaco-epidemiologie

Sekseverschillen in bijwerkingen

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Linda Hendriksen
  • Promoters L.E. Visser (EMC/Haga) R. Herings (Amsterdam UMC)
  • Co-Promoters P. van der Linden (Tergooi)
  • Jaar 2018 - 2025
Farmaco-epidemiologie

The long-term outcomes of older adults with COVID-19

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Julia Minnema
  • Promoters Hugo van der Kuy Francesco Mattace-Raso
  • Co-Promoters Miriam Faes Harmke Polinder-Bos
  • Jaar 2022-2025

To describe the impact of COVID-19 on the continuity of care in the primary care setting.
To describe the impact of delirium and frailty on clinical outcomes in COVID-19 patients admitted to the hospital.
To describe the impact of delirium on recovery of COVID-19 patients in geriatric rehabilitation.
To describe perceptions, motivations, needs and experiences of geriatricians with scientific research.
 

Farmaco-epidemiologie

Socioeconomic determinants of psychotropic medication use in children and adolescents

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Ravish Gangapersad
  • Promoters Birigit Koch Pilar Garcia-Gomez
  • Co-Promoters Bram Dierckx Vahid Moghani
  • Jaar 2022-2026

My research focuses on the socioeconomic determinants of psychotropic medication use in children and adolescents. Specifically, I aim to identify the complex relationships between socioeconomic factors and psychotropic medication use in young people, and to explore potential avenues for improving health outcomes in this vulnerable population.
 

Medicatieveiligheid

Optimizing therapy in patients suffering from statin-intolerance: n=1 trials.

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Ruben Mijnster
  • Promoters Hugo van der Kuy
  • Co-Promoters Melvin Lafeber Jeanine Roeters-van Lennep
  • Jaar 2024-2028

My research focuses on the occurence of nocebo-effects in statin-intolerant. We try to identify patients who are statin-intolerant and that suffer from these effects. We hope that by identifying patients affected by the nocebo effect and allowing them to experientially understand its impact through an N=1 study design, they will experience fewer side effects from their statin treatment. This may help prevent the need to switch to expensive PCSK9 inhibitors.
 

Medicatieveiligheid

Improving pharmaceutical care for hospitalized patients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Sarah Wilkes
  • Promoters Hugo van der Kuy
  • Co-Promoters Rianne Zaal
  • Jaar 2022-2026

Cost benefit analysis clinical medication reviews. Follow up of interventions from clinical pharmacists. Medication information needs of hospitalized patients.
 

Medicatieveiligheid

Improving pharmaceutical care for hospitalized patients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Sarah Wilkes
  • Promoters Hugo van der Kuy
  • Co-Promoters R.J. Zaal
  • Jaar 2022-2026
  1. Cost benefit analysis clinical medication reviews
  2. Follow up of interventions from clinical pharmacists.
  3. Medication information needs of hospitalized patients.